These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12371851)

  • 1. Inhibitor scaffolds as new allele specific kinase substrates.
    Kraybill BC; Elkin LL; Blethrow JD; Morgan DO; Shokat KM
    J Am Chem Soc; 2002 Oct; 124(41):12118-28. PubMed ID: 12371851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src.
    Liu Y; Shah K; Yang F; Witucki L; Shokat KM
    Bioorg Med Chem; 1998 Aug; 6(8):1219-26. PubMed ID: 9784863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for selective inhibition of Src family kinases by PP1.
    Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
    Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificities.
    Liu Y; Witucki LA; Shah K; Bishop AC; Shokat KM
    Biochemistry; 2000 Nov; 39(47):14400-8. PubMed ID: 11087392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering a "methionine clamp" into Src family kinases enhances specificity toward unnatural ATP analogues.
    Ulrich SM; Kenski DM; Shokat KM
    Biochemistry; 2003 Jul; 42(26):7915-21. PubMed ID: 12834343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pp60c-Src inhibitor PP1 is non-competitive against ATP.
    Karni R; Mizrachi S; Reiss-Sklan E; Gazit A; Livnah O; Levitzki A
    FEBS Lett; 2003 Feb; 537(1-3):47-52. PubMed ID: 12606029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Src family protein kinases with unnatural nucleotide specificity.
    Liu Y; Shah K; Yang F; Witucki L; Shokat KM
    Chem Biol; 1998 Feb; 5(2):91-101. PubMed ID: 9495830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational restraint is a critical determinant of unnatural nucleotide recognition by protein kinases.
    Ulrich SM; Sallee NA; Shokat KM
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3223-7. PubMed ID: 12372539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme.
    Witucki LA; Huang X; Shah K; Liu Y; Kyin S; Eck MJ; Shokat KM
    Chem Biol; 2002 Jan; 9(1):25-33. PubMed ID: 11841936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides.
    Chen G; Porter MD; Bristol JR; Fitzgibbon MJ; Pazhanisamy S
    Biochemistry; 2000 Feb; 39(8):2079-87. PubMed ID: 10684658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the serine/threonine protein kinase Raf-1 to utilise an orthogonal analogue of ATP substituted at the N6 position.
    Hindley AD; Park S; Wang L; Shah K; Wang Y; Hu X; Shokat KM; Kolch W; Sedivy JM; Yeung KC
    FEBS Lett; 2004 Jan; 556(1-3):26-34. PubMed ID: 14706820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.
    Zhou HR; Jia Q; Pestka JJ
    Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic mechanism and ATP-binding site reactivity of p38gamma MAP kinase.
    Fox T; Fitzgibbon MJ; Fleming MA; Hsiao HM; Brummel CL; Su MS
    FEBS Lett; 1999 Nov; 461(3):323-8. PubMed ID: 10567720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate signaling by Src and p38 kinases in the induction of cortical cataracts.
    Zhou J; Menko AS
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2314-23. PubMed ID: 15223811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant-induced priming of the macrophage involves activation of p38 mitogen-activated protein kinase through an Src-dependent pathway.
    Khadaroo RG; Parodo J; Powers KA; Papia G; Marshall JC; Kapus A; Rotstein OD
    Surgery; 2003 Aug; 134(2):242-6. PubMed ID: 12947324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically reprogramming the phospho-transfer reaction to crosslink protein kinases to their substrates.
    Wong AW; Urisman A; Burlingame AL; Shokat KM
    Protein Sci; 2019 Mar; 28(3):654-662. PubMed ID: 30636329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic reaction pathway for the mitogen-activated protein kinase ERK2.
    Prowse CN; Hagopian JC; Cobb MH; Ahn NG; Lew J
    Biochemistry; 2000 May; 39(20):6258-66. PubMed ID: 10821702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues.
    Sundaramoorthi R; Shakespeare WC; Keenan TP; Metcalf CA; Wang Y; Mani U; Taylor M; Liu S; Bohacek RS; Narula SS; Dalgarno DC; van Schravandijk MR; Violette SM; Liou S; Adams S; Ram MK; Keats JA; Weigle M; Sawyer TK; Weigele M
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3063-6. PubMed ID: 12941334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.